<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04114604</url>
  </required_header>
  <id_info>
    <org_study_id>CAPCR 16-6310 (NIH_SCI)</org_study_id>
    <secondary_id>5R01DC011020</secondary_id>
    <secondary_id>CAPCR 16-6310</secondary_id>
    <nct_id>NCT04114604</nct_id>
  </id_info>
  <brief_title>Respiratory Capacity and Swallowing Function in Spinal Disorders: A Pilot Study</brief_title>
  <official_title>Respiratory Capacity and Swallowing Function in Spinal Disorders: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of a larger grant, for which the overall goal is to collect measurements
      of liquid flow through the oropharynx (i.e., mouth and throat) during swallowing.The focus of
      this study is to evaluate the flow of liquids of varying consistency in the spinal disorder
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thickened liquids are commonly used as an intervention for dysphagia (swallowing impairment).
      However, the field lacks a clear understanding of how liquids of different consistencies
      behave during swallowing. In order to improve understanding of the effectiveness of altered
      liquid consistency for improving dysphagia, the investigators are studying liquid flow
      through the oropharynx. This study explores this question in individuals with spinal cord
      injury. Participants will swallow 20% w/v barium thickened to different consistencies (thin,
      slightly thick, mildly thick, moderately thick and extremely thick) using commercially
      available food thickeners. Swallowing will be observed under videofluoroscopy. Simultaneous
      measures of airflow via nasal cannula will be used to study respiratory-swallow coordination
      in this study sample.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 30, 2017</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All enrolled participants will complete the study protocol.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Penetration-Aspiration Scale (Swallow Safety)</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The Penetration-Aspiration Scale (rosenbek et al., 1996) is an 8-point scale that will be used to characterize swallowing safety for each bolus trial based on the depth to which any material etners the airway and whether or not the material is ejected. Levels 1 and 2 on the scale are considered safe, while levels &gt; 3 are considered unsafe. Actual scale scores (1-8) will be recorded and then converted to binary categorical scores (&lt; 3 vs. &gt;/= 3).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swallowing Efficiency</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>Pixel-based measures of post-swallow residue in the pharynx will be performed on the videofluoroscopy recordings.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of swallows per bolus</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The number of swallows needed to clear a single bolus will be counted. 1-2 swallows is considered efficient, while &gt; 2 for a single bolus is considered inefficient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swallow Reaction Time</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The time interval between the bolus passing the ramus of the mandible (jaw) and onset of the hyoid burst movement in swallowing will be calculated (in milliseconds) for each bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hyoid burst to Upper Esophageal Sphincter Opening Interval</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The time interval between onset of the hyoid burst and opening of the upper esophageal sphincter will be measured (in milliseconds) for each bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Upper Esophageal Sphincter Opening Duration</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The time interval between opening and closing of the upper esophageal sphincter will be measured for each bolus (in milliseconds).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time-to-Laryngeal-Vestibule-Closure</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The time interval between onset of the hyoid burst and achieving closure of the laryngeal vestibule will be measured for each bolus (in milliseconds)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laryngeal Vestibule Closure Duration</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The time interval between laryngeal vestibule closure onset and offset will be measured for each bolus (in milliseconds)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum Pharyngeal Constriction</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The degree of pharyngeal constriction will be measured using pixel-based tracing in ImageJ software on the frame of maximum constriction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharyngeal Area at Rest</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The size of the pharynx will be measured at rest using pixel-based tracing in ImageJ software.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Upper Esophageal Sphincter Opening diameter</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The diameter of upper esophageal sphincter opening on the frame of maximum distension will be measured using pixel-based tracing in Image J software.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Direction of Airflow</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The direction of breathing (inspiration/expiration) airflow will be measured continuously via nasal cannula using the airflow module of the KayPentax Digital Swallow Workstation Swallowing Signals Lab. This information will be used to identify the direction of airflow immediately preceding and immediately following each swallow. An expiration-swallow-expiration pattern is considered normal. All other variants (inspiration-swallow-expiration, inspiration-swallow-expiration, expiration-swallow-inspiration) are considered abnormal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Respiratory Pause</measure>
    <time_frame>Baseline (single timepoint only)</time_frame>
    <description>The duration of the pause in respiration (in milliseconds) seen with each swallow will be measured from the continuous airflow waveform collected via nasal cannula using the airflow module of the KayPentax Digital Swallow Workstation Swallowing Signals Lab.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Deglutition Disorders</condition>
  <arm_group>
    <arm_group_label>Spinal Cord Injury</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adults who have sustained a spinal cord injury at the cervical or upper thoracic level (T6 or higher). Participants will swallow 20% w/v barium (E-Z-Paque) thickened to different consistencies using starch or xanthan-gum based food thickeners.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Starch-based thickened liquids</intervention_name>
    <description>Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.</description>
    <arm_group_label>Spinal Cord Injury</arm_group_label>
    <other_name>Nestle Resource ThickenUp</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Xanthan-gum thickened liquids</intervention_name>
    <description>Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.</description>
    <arm_group_label>Spinal Cord Injury</arm_group_label>
    <other_name>Nestle Resource ThickenUp Clear</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Spinal cord injury at the cervical or thoracic level (T6 or higher)

        Exclusion Criteria:

          -  Prior history of swallowing, motor speech, gastro‚Äêesophageal difficulties, chronic
             sinusitis or taste disturbance.

          -  Neurological difficulties unrelated to spinal disorder (e.g. Stroke, Parkinson
             disease, etc).

          -  Cognitive communication difficulties that may hinder ability to participate.

          -  Current use of mechanical ventilation

          -  External instrumentation around the head/neck that would obstruct the field of view
             during the videofluoroscopy exam (e.g. cervical collar).

          -  Type 1 Diabetes (due to the requirement to swallow stimuli containing starch based
             thickeners, which carry a significant carbohydrate load).

          -  Known allergies to latex, food coloring or dental glue (due to the probability that
             these items will come into contact with the oral mucosa during data collection).

          -  Children and pregnant women (due to the use of radiation during the videofluoroscopic
             examination).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catriona Steele</last_name>
    <role>Principal Investigator</role>
    <affiliation>KITE - Toronto Rehabilitation Institute, University Health Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto Rehabilitation Institute - Lyndhurst Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 27, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2019</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Deglutition Disorders</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>not planned at this time</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

